New strategy for COVID-19 prophylaxis?
The Pharma Data
MARCH 8, 2022
However, the antiviral immune receptor RIG-I can be stimulated, which improves protection against lethal SARS-CoV-2 infections. While the development of vaccines was accomplished in a remarkably short timeframe, the identification of direct antiviral treatments has progressed comparatively slowly. Researchers led by Prof.
Let's personalize your content